Live Breaking News & Updates on Kavikrishna Foundation

Stay updated with breaking news from Kavikrishna foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines


Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines
The SARS-CoV-2 virus that causes COVID-19 may have the ability to reactivate dormant tuberculosis (TB). In a novel study scientists report in
The American Journal of Pathology that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis (MTB) in mice. This knowledge may help to develop new vaccines for COVID-19 and avoid a potential global tuberculosis epidemic.
The COVID-19 pandemic caused by the SARS-CoV-2 virus demonstrates the ability of an emerging virus to affect masses and strain and disrupt the workings of modern healthcare systems around the world. A significant number of infected COVID-19 individuals have recovered. However, a possible host defense or antiviral mechanism against the virus is yet to be identified. There are concerns that in the long-term, the virus might activate dormant bacterial infections such as TB in select in ....

United States , Upakarvada Vedic , Lekhika Pathak , Bikul Das , Herman Yeger , Krishna Ram Das , Emily Henderson , Kavikrishna Foundation , Department Of Pediatric Laboratory Medicine , Kavikrishna Laboratory , University Of Massachusetts , Department Of Stem Cell , Indian Institute Of Technology , Kavikrishna Lab , Thoreau Lab For Global Health , American Journal , Lead Investigator , Stem Cell , Infectious Diseases , Guwahati Biotech Park , Indian Institute , Thoreau Lab , Global Health , Indian Vedantic Philosophical , Vedic Jiva Upakarvada , Pediatric Laboratory Medicine ,